Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 1/2 1Phase 1 1

Status

Completed 5Active not recruiting 4Unknown 3Recruiting 2Withdrawn 1Terminated 1

Sponsor Class

INDUSTRY 17OTHER 5

Study Type

Interventional 5

Sponsor

Cancer Type

Breast 4Tumor-Agnostic 1

Conditions

Triple Negative Breast Neoplasms 2Breast Neoplasms 2Neoplasm Metastasis 1

Interventions

Cyclophosphamide 956Radiotherapy 847Cisplatin 757Gemcitabine 657Carboplatin 603Docetaxel 598Paclitaxel 585Bevacizumab 580Fluorouracil 504Oxaliplatin 458Rituximab 453Surveys and Questionnaires 449Capecitabine 440Dexamethasone 428Doxorubicin 424Etoposide 411Irinotecan 389Cytarabine 376Filgrastim 369pembrolizumab 330Leucovorin 305Nivolumab 296fludarabine phosphate 294Melphalan 288Magnetic Resonance Spectroscopy 281Peripheral Blood Stem Cell Transplantation 279Blood Specimen Collection 279Methotrexate 276Lenalidomide 276Cetuximab 270

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Completed × OTHER × ipatasertib × Clear all
NCT04253561 2026-03-16

IPATHER

SOLTI Breast Cancer Research Group

Phase 1 Completed
17 enrolled
Breast

Breast Neoplasms

NCT04551521 2025-01-08

CRAFT: The NCT-PMO-1602 Phase II Trial

German Cancer Research Center

Phase 2 Completed
72 enrolled
Tumor-Agnostic

Neoplasm Metastasis

NCT04464174 2024-07-26

PATHFINDER

MedSIR

Phase 2 Completed
54 enrolled
Breast

Triple Negative Breast Neoplasms

NCT03395899 2024-06-18

ECLIPSE

Queen Mary University of London

Phase 2 Completed
71 enrolled
Breast

Breast Neoplasms

NCT03853707 2024-02-20

Ipatasertib in Combination With Carboplatin, Carboplatin/Paclitaxel, or Capecitabine/Atezolizumab in Treating Patients With Metastatic Triple Negative Breast Cancer

City of Hope Medical Center

Phase 1/2 Completed
28 enrolled 12 charts
Breast

Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡